STRONG Program for Cancer Patients
Launched by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE · Dec 6, 2022
Trial Information
Current as of January 21, 2025
Active, not recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Gastrointestinal Cancer diagnosis (e.g., colon cancer, appendiceal cancer)
- • Peritoneal disease diagnosis
- • Received Cytoreductive Surgery and Heated Intra-Peritoneal Chemotherapy (CRS-HIPEC) for curative intent at Moffitt
- • Transitioned to an oral diet post-surgery
- • Able to speak and read English
- • Able to provide informed consent
- Exclusion Criteria:
- • Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse)
- • Undergoing concurrent treatment for a secondary primary cancer
- • Receipt of parenteral or enteral nutrition after surgery
Trial Officials
Amir Alishahi Tabriz, MD, PhD, MPH
Principal Investigator
Moffitt Cancer Center
Ben Powers, MD
Principal Investigator
Moffitt Cancer Center
About H. Lee Moffitt Cancer Center And Research Institute
H. Lee Moffitt Cancer Center and Research Institute is a leading institution dedicated to cancer research, treatment, and education, recognized for its commitment to advancing cancer care through innovative clinical trials and groundbreaking research. As a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt integrates cutting-edge science with patient-centered care, offering a multidisciplinary approach to cancer treatment. The center is at the forefront of developing novel therapies and improving outcomes for patients, emphasizing collaboration between researchers and clinicians to translate scientific discoveries into effective treatments. Through its extensive clinical trial programs, Moffitt aims to enhance the understanding of cancer biology and provide patients with access to the latest therapies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials